http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013203266-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea803fedb641d0973cb43b9fbea9840f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2013-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79858df341fc97ace6612f1bd7e235a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ee14459309a18becf1f44122d51456 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca55d0d2a3214663971b0e3e80ad520 |
| publicationDate | 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013203266-B2 |
| titleOfInvention | Variants derived from ActRIIB and uses therefor |
| abstract | In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, 5 fat, and/or neuronal tissue. The present invention also provides methods of screening compounds that modulate activity of an ActRIIB protein and/or an ActRIIB ligand. The compositions and methods provided herein are useful in treating diseases associated with abnormal activity of an ActRIIB protein and/or an ActRIIB ligand. |
| priorityDate | 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 698.